Vasodilator mechanism of intermedin/adrenomedullin-2 in anesthetized rats

Proceedings of the Western Pharmacology Society

Volumn 50, Issue , 2007, Pages 43-46

  Abdelrahman, Aly Mohamed ^b   Pang, Catherine Cheuk Ying ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b SULTAN QABOOS UNIVERSITY   (Oman)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ARGININE; ENZYME INHIBITOR; INDOMETACIN; INTERMEDIN PROTEIN, RAT; MECAMYLAMINE; N(G) NITROARGININE METHYL ESTER; NEUROPEPTIDE; NICOTINIC RECEPTOR BLOCKING AGENT; NITRIC OXIDE; POTASSIUM CHANNEL BLOCKING AGENT; PROSTAGLANDIN; TETRYLAMMONIUM; VASODILATOR AGENT;

ANESTHESIA; ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD PRESSURE; DRUG EFFECT; HEART RATE; MALE; METABOLISM; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ADRENOMEDULLIN; ANESTHESIA; ANIMALS; ARGININE; BLOOD PRESSURE; ENZYME INHIBITORS; HEART RATE; INDOMETHACIN; MALE; MECAMYLAMINE; NEUROPEPTIDES; NG-NITROARGININE METHYL ESTER; NICOTINIC ANTAGONISTS; NITRIC OXIDE; POTASSIUM CHANNEL BLOCKERS; PROSTAGLANDINS; RATS; RATS, SPRAGUE-DAWLEY; TETRAETHYLAMMONIUM; VASODILATOR AGENTS;

EID: 48249135757     PISSN: 00838969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Roh, J., Chang, C.L., Bhalla, A., Klein, C. and Hsu, S.Y. (2004) J. Biol. Chem. 279, 7264-7274.
2. Takei, Y., Inoue, K., Ogoshi, M., Kawahara, T., Bannai, H. and Miyano, S. (2004) FEBS Letters 556, 53-58.
3. Taylor, M.M., Bagley, S.L. and Samson, W.K. (2005) Am. J. Physiol. 288, R919-R927.
4. Taylor, M.M., Bagley, S.L. and Samson, W.K. (2006) Endocrinology 147, 859-864.
5. Chang, C.L., Roh, J., Park, J., Klein, C., Cushman, N., Haberberger, R.V. and Hsu, S.Y.T. (2005) Mol. Endocrinol. 19, 2824-2838.
6. Hashimoto, H., Hyodo, S., Kawasaki, M., Mera, T., Chen, L., Soya, A., Saito, T., Fujihara, H., Higuchi, T., Takei, Y. and Ueta, Y. (2005) Am. J. Physiol. 289, E753-E761.
7. Fujisawa, Y., Nagai, Y., Miyatake, A., Takei, Y., Miura, K., Shoukouji, T., Nishiyama, A., Kimura, S. and Abe, Y. (2004) Eur. J. Pharmacol. 497, 75-80.
8. Takei, Y., Hyodo, S., Katafuchi, T. and Minamino, N. (2004) Peptides 25, 1643-1656.
9. Fujisawa, Y., Nagai, Y., Miyatake, A., Miura, K., Shokoji, T., Nishiyama, A., Kimura, S. and Abe, Y. (2006) Am. J. Physiol. 290, H1120-H1127.
10. Ren, Y.-S., Yang, J.-H., Zhang, J., Pan, C.-S., Yang, J., Zhao, J., Pang, Y.-Z., Tang, C.-S. and Qi, Y.-F. (2006) Peptides 27, 74-79.
11. Abdelrahman, A. and Pang, C.C.Y. (2006) N.-S. Arch. Pharmacol. 272, 276-380.
12. Dong, F., Taylor, M.M., Samson, W.K. and Ren, J. (2006) J. Appl. Physiol. 101, 778-784.
13. Wang, Y.X., Lim, S.L. and Pang, C.C.Y. (1995) Br. J. Pharmacol. 114, 1454-1458.
14. Silva-Santos, J.E. and Assreuy, J. (1999) J. Pharmacol. Exp. Ther. 290, 380-387.
15. Wang, Y.X., Cheng, X. and Pang, C.C.Y. (1995) Br. J. Pharmacol. 114, 194-202.
16. Wang, Y.X. and Pang, C.C.Y. (1991) Br. J. Pharmacol. 103, 2004-2008.
17. Petersen, J.S. and DiBona, G.F. (1992) Hypertension 19, 814-817.
18. Kandilici, H.B., Gumusel, B., Wasserman, A., Witriol, N. and Lippton, H. (2006) Peptides 27, 1390-1396.
19. Pan, C.-S., Yang, J.-H., Cai, D.-Y., Zhao, J., Gerns, H., Yang, J., Chang, J.-K., Tang, C.-S. and Qi Y.-F. (2005) Peptides 26, 1640-1646.
20. Yang, J.H., Qi, Y.F., Jia, Y.X., Pan, C.S., Zhao, J., Yang, J., Chang, J.K. and Tang, C.S. (2005) Peptides 26, 501-507.
21. Yang, J.H., Pan, C.S., Jia, Y.X., Zhang, J., Zhao, J., Pang, Y.-Z., Yang, J., Tang, C.-S. and Qi, Y.F. (2006) Biochem. Biophys. Res. Commun. 341, 567-572.